Li Weng

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Acute Respiratory Distress Syndrome

Extracorporeal Membrane Oxygenation

Top Venues

American journal of respiratory and critical care medicine

Antimicrobial agents and chemotherapy

Intensive care medicine experimental

Critical care medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Rong Liufu, Li Weng, Chun-Yao Wang, Bin Du
Pitfalls of Acute Respiratory Distress Syndrome Diagnosis Based on Interventions. American journal of respiratory and critical care medicine 209 (10) (2024)
Rong Liufu, Li Weng, Chun-Yao Wang, Bin Du
Pitfalls of Acute Respiratory Distress Syndrome Diagnosis Based on Interventions. American journal of respiratory and critical care medicine 209 (10) (2024)
Yang Xu, Yi-Fan Wang, Yi-Wei Liu, Run Dong, Yan Chen, Yi Wang, Li Weng, Bin Du, null null
The Impact of Delayed Transition From Noninvasive to Invasive Mechanical Ventilation on Hospital Mortality in Immunocompromised Patients With Sepsis. Critical care medicine (2024)
Rong Liufu, Li Weng, Chun-Yao Wang, Bin Du
Pitfalls of Acute Respiratory Distress Syndrome Diagnosis Based on Interventions. American journal of respiratory and critical care medicine 209 (10) (2024)
Rong Liufu, Li Weng, Chun-Yao Wang, Bin Du
Pitfalls of Acute Respiratory Distress Syndrome Diagnosis Based on Interventions. American journal of respiratory and critical care medicine 209 (10) (2024)
Rong Liufu, Li Weng, Chun-Yao Wang, Bin Du
Pitfalls of Acute Respiratory Distress Syndrome Diagnosis Based on Interventions. American journal of respiratory and critical care medicine 209 (10) (2024)
Rong Liufu, Li Weng, Chun-Yao Wang, Bin Du
Pitfalls of ARDS Diagnosis Based on Interventions. American journal of respiratory and critical care medicine (2024)
Shu-Hua He, Shan Li, Li Weng
False-positive Legionella pneumophila antibodies in COVID-19 patients. Intensive care medicine experimental 11 (1) (2023)
Run Dong, Li Jiang, Ting Yang, Changsong Wang, Yi Zhang, Xu Chen, Jianfeng Xie, Yuanbin Guo, Li Weng, Yan Kang, Kaijiang Yu, Haibo Qiu, Bin Du, null null
Efficacy and Safety of SARS-CoV-2 Neutralizing Antibody JS016 in Hospitalized Chinese Patients with COVID-19: a Phase 2/3, Multicenter, Randomized, Open-Label, Controlled Trial. Antimicrobial agents and chemotherapy 66 (3) (2022)